RxDoctor Payments Data

Jaclyn Weber, PA

Physician Assistant · New Boston, MINPI 1992371702

Payments from drug & device makers

$369in general payments, 2019–2025

Across 12 payments — averaging $30.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cardiovascular Systems Inc.$135
  • AbbVie$46
  • Novo Nordisk$44
  • Exact Sciences$41
  • Boston Scientific$27
  • GSK$23
  • plus $53 from 3 others

What the payments were for

  • Food & beverage$369100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$369 in reported general payments places this provider in the 60th percentile of 5,453 physician assistant providers in Michigan.

See all physician assistant providers in Michigan

Medicare billing

Part B allowed, 2024
$19,480
Medicare patients
68
Services billed
393

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter24$26,181
JardianceEmpagliflozin21$21,765
EliquisApixaban19$20,747
TrulicityDulaglutide16$17,142
JanuviaSitagliptin Phosphate22$15,725
OzempicSemaglutide13$13,997
FarxigaDapagliflozin Propanediol12$13,455
Albuterol Sulfate HfaAlbuterol Sulfate46$1,490
Atorvastatin Calcium161$1,395
Omeprazole56$921
Levothyroxine Sodium69$816
Gabapentin51$714
Lisinopril102$711
Mirtazapine12$605
Losartan Potassium57$593

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta$23$26,18124 claims
Lilly USA, LLCTrulicity$14$17,14216 claims
Novo NordiskOzempic$44$13,99713 claims
AstraZenecaFarxiga$21$13,45512 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 5,453 physician assistant providers in Michigan.

Other physician assistant in New Boston

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →